Clinical Trial Update: A Long-term Follow-up Study in Participants Who Received CS-101

View source ↗

Summary

This clinical trial update reports a long-term follow-up study of participants who received CS-101 for beta-thalassemia. Enrollment is by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-thalassemia

Drugs mentioned

• CS-101

Snippet

Sponsor: CorrectSequence Therapeutics Co., Ltd | Conditions: Beta-Thalassemia | Status: ENROLLING_BY_INVITATION